VTGN - VistaGen Therapeutics adds Maggie FitzPatrick to its board of directors
VistaGen Therapeutics (VTGN) announces the appointment of Maggie FitzPatrick to the company's board of directors.FitzPatrick replaces Brian Underdown who recently retired from the board.Recently, she served as a member of the Exelon Corporation executive committee.
For further details see:
VistaGen Therapeutics adds Maggie FitzPatrick to its board of directors